Feasibility of the Loop Brush EUS-FNA for Characterization of Pancreatic Cysts: Pilot Clinical Investigation
PCLoop-Pilot
1 other identifier
interventional
8
1 country
1
Brief Summary
This investigation aims to demonstrate the feasibility of the lbFNA device for the first time in pancreatic cysts in humans. This study will be used as a base for further investigations on the safety and diagnostic accuracy of the lbFNA device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pancreatic-cancer
Started Oct 2026
Shorter than P25 for not_applicable pancreatic-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2026
CompletedFirst Posted
Study publicly available on registry
September 10, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
September 10, 2026
September 1, 2026
1.4 years
September 2, 2026
September 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Integrity of the lbFNA device
Integrity of the device after withdrawing from the patient, evaluated according to a separate inspection protocol with special focus on the loop.
From start of the lbFNA procedure until completion of the lbFNA procedure.
Study Arms (1)
Loop Brush Fine Needle Aspiration
EXPERIMENTALInterventions
Loop Brush Fine Needle Aspiration (lbFNA) device is an endoscopy instrument used in this investigation for the puncture, brushing and aspiration of pancreatic cystic lesions prior to surgical removal of the pancreatic cystic lesion.
Eligibility Criteria
You may qualify if:
- Pancreatic cystic lesions that require surgical resection according to MDT conference
- Assessed as fit for surgery
- Age \>18 years
- Given written informed consent to participate
You may not qualify if:
- Pregnancy
- Cyst not accessible by lbFNA
- Cyst not accessible for resection that includes the puncture canal for lbFNA
- Cyst with calcified content
- Inability to understand written or oral information, which hinders the ability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Urban Arnelolead
Study Sites (1)
Department of Surgery, Umeå University Hospital
Umeå, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Consultant Surgeon, Professor
Study Record Dates
First Submitted
September 2, 2026
First Posted
September 10, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
September 10, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share